Our Co-Founders, Joshua and Tetsuro, Participated in the Antler Japan Residency Program 3

After 10 weeks of the Antler Japan Residency Program 3, we are proud to announce that our co-founders, Joshua and Tetsuro, have successfully completed the program.

ModAsteraPublished 18 Dec 2024

1 min read

We are proud to announce that our co-founders, Joshua and Tetsuro, participated in the Antler Japan Residency Program 3. After 10 weeks of the program, they have successfully completed the program. ModAstera is now a part of the Antler Japan family. ModAstera will continue receive support from Antler Japan while working on our mission to accelerate the development of healthcare AI.

Written by ModAstera

The team behind MAEA, the medical AI engineering agent.

News
ModAstera Joins the J-StarX UK HealthTech Launchpad
ModAstera joins JETRO's UK HealthTech Launchpad to validate a focused pathology workflow and prepare for clinical and commercial partnerships in the UK.
3 min read · 14 Aug 2026
News
ModAstera and Wellgen Medical Announce Strategic AI Collaboration to Transform Cancer Cytology Diagnostics
ModAstera and Wellgen Medical are partnering to build AI screening models for cancer cytology, combining FDA-cleared tomographic imaging, clinical datasets, and rapid medical AI deployment.
2 min read · 28 Apr 2026
News
Welcome Prof. Christian Aldridge as Chief Medical Officer
ModAstera welcomes Prof. Christian Aldridge, a leading UK dermatologist and skin cancer authority, as Chief Medical Officer to drive clinical governance across Hebra and MAEA.
1 min read · 2 Mar 2026

Building a medical AI workflow like this?

Talk to the team that builds MAEA about your data, evaluation and review workflow.

Explore MAEA

Related posts

ModAstera Joins the J-StarX UK HealthTech Launchpad

ModAstera and Wellgen Medical Announce Strategic AI Collaboration to Transform Cancer Cytology Diagnostics

Welcome Prof. Christian Aldridge as Chief Medical Officer

Building a medical AI workflow like this?